Gritstone Oncology, Inc.
(NASDAQ : GRTS)

( )
GRTS PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
0.98%130.410.6%$1854.65m
PFEPfizer Inc.
-1.65%42.400.9%$1031.14m
MRKMerck & Co., Inc.
-1.21%74.320.6%$1004.81m
LLYEli Lilly and Company
-1.70%106.521.0%$498.83m
BMYBristol-Myers Squibb Company
1.26%51.561.4%$493.13m
ABBVAbbVie, Inc.
-1.58%83.592.2%$478.65m
NVSNovartis AG Sponsored ADR
-0.43%85.390.2%$227.77m
AZNAstraZeneca PLC Sponsored ADR
-0.31%38.231.3%$183.45m
GSKGlaxoSmithKline plc Sponsored ADR
0.05%37.090.2%$155.06m
NVONovo Nordisk A/S Sponsored ADR Class B
-1.88%45.320.1%$76.46m
SNYSanofi Sponsored ADR
-0.87%43.200.2%$45.06m
LCILannett Company, Inc.
0.00%4.5637.0%$7.59m
AKTXAkari Therapeutics Plc Sponsored ADR
0.00%1.761.7%$0.03m
EPIXESSA Pharma Inc
0.00%2.450.1%$0.00m

Company Profile

Gritstone Oncology, Inc. provides cancer immunotherapy therapeutics services. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria and is headquartered in Emeryville, CA.